Capricor Therapeutics Inc... (CAPR)
NASDAQ: CAPR
· Real-Time Price · USD
12.82
0.12 (0.94%)
At close: May 01, 2025, 3:59 PM
13.00
1.36%
After-hours: May 01, 2025, 06:20 PM EDT
Capricor Therapeutics Revenue
Capricor Therapeutics reported an annual revenue of $22.27M, reflecting a -11.55% growth. For the quarter ending December 31, 2024, Capricor Therapeutics generated $11.13M in revenue.
Revenue (ttm)
$22.27M
Revenue Growth
-11.55%
Price / Sales Ratio
21.82
Revenue / Employee
$139.19K
Employees
160
Market Cap
585.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 22.27M | -11.55% |
| Dec 31, 2023 | 25.18M | +887.79% |
| Dec 31, 2022 | 2.55M | +940.81% |
| Dec 31, 2021 | 244.9K | -21.06% |
| Dec 31, 2020 | 310.25K | n/a |